Multicenter Surveillance of Streptococcus pneumoniae Isolates From Middle Ear and Mastoid Cultures in the 13-Valent Pneumococcal Conjugate Vaccine Era
Clinical Infectious Diseases2015Vol. 60(9), pp. 1339–1345
Citations Over TimeTop 10% of 2015 papers
Sheldon L. Kaplan, William J. Barson, Philana Ling-Lin, José R. Romero, John S. Bradley, Tina Q. Tan, Jill A. Hoffman, Timothy R. Peters, Alejandra Gurtman, Daniel A. Scott, James Trammel, William C. Gruber, Kristina G. Hultén, Edward O. Mason
Abstract
The number of pneumococcal isolates and the percentage of isolates with high-level penicillin resistance from cultures taken from children with OM or mastoiditis for clinical indications have decreased following PCV13 use, largely related to decreases in serotype 19A isolates.
Related Papers
- → Serotype Distribution of Streptococcus pneumoniae Infections among Preschool Children in the United States, 1978-1994: Implications for Development of a Conjugate Vaccine(1995)251 cited
- → Implications of Streptococcus pneumoniae Penicillin Resistance and Serotype Distribution in Kuwait for Disease Treatment and Prevention(2007)29 cited
- → Serotype and Clonal Evolution of Penicillin-Nonsusceptible Invasive Streptococcus pneumoniae in the 7-Valent Pneumococcal Conjugate Vaccine Era in Italy(2012)28 cited
- → Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines(2009)5 cited
- → First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants(2018)2 cited